AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 9033-9033 ◽  
Author(s):  
R. Dummer ◽  
C. Robert ◽  
P. B. Chapman ◽  
J. A. Sosman ◽  
M. Middleton ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Melanoma ◽  
Open Label ◽  
Multicenter Phase

Nivolumab (NIVO) safety in patients with advanced melanoma (MEL) who have progressed on or after ipilimumab (IPI): A single-arm, open-label, multicenter, phase II study (CheckMate 172).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 9526-9526 ◽  
Author(s):  
Paolo Antonio Ascierto ◽  
Lev V. Demidov ◽  
Claus Garbe ◽  
Paul Lorigan ◽  
Helen Gogas ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Melanoma ◽  
Open Label ◽  
Multicenter Phase

scholarly journals Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study

2018 ◽  
Vol 105 ◽  
pp. 114-126 ◽  
Author(s):  
Kenjiro Namikawa ◽  
Yoshio Kiyohara ◽  
Tatsuya Takenouchi ◽  
Hisashi Uhara ◽  
Hiroshi Uchi ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Advanced Melanoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Multicentre Phase

A single-arm, open-label, multicenter phase II trial (CheckMate 172) of nivolumab (NIVO) safety in European patients (pts) with advanced melanoma (MEL) who have progressed after ipilimumab therapy (IPI).

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. TPS9083-TPS9083
Author(s):  
Dirk Schadendorf ◽  
Paolo Antonio Ascierto ◽  
Enrique Espinosa ◽  
John B. A. G. Haanen ◽  
Frank Hermann ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Melanoma ◽  
Open Label ◽  
Multicenter Phase
Sign in / Sign up

Export Citation Format

Share Document